% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Schweitzer:1027025,
author = {Schweitzer, Finja and Ladwig, Anne and Opala, Sarah and
Laurent, Sarah and Schroeter, Michael and Goelz, Susan and
Fink, Gereon R. and Wieland, Ulrike and Silling, Steffi and
Warnke, Clemens},
title = {{A}bsence of {JC} polyomavirus in stool samples of patients
with multiple sclerosis despite high anti-{JCV} antibodies
in serum},
journal = {Multiple Sclerosis and Related Disorders},
volume = {87},
issn = {2211-0348},
address = {Amsterdam [u.a.]},
publisher = {Elsevier},
reportid = {FZJ-2024-03591},
pages = {105664 -},
year = {2024},
abstract = {Background: Natalizumab is an effective treatment for
relapsing multiple sclerosis (MS). During therapy,
individualsare at increased risk of developing progressive
multifocal leukoencephalopathy (PML). So far, therelevant
reservoir for PML-type JC polyomavirus (JCV) remains
elusive. We here tested if the detection of JCVDNAin stool
of persons with MS treated with natalizumab could be a
future tool for PML risk assessment.Methods: The presence of
JCV-DNA in stool, urine, and whole blood of MS patients
treated with natalizumab andknown serum anti-JCV antibodies
index values (IV) was studied. Different DNA extraction
methods, real-time(RT) and droplet digital (dd) PCR
techniques were compared. JCV isolates were screened for
PML-associatedvariants by sequencing.Results: Thirty MS
patients treated with natalizumab were screened. For 21
patients, blood, stool, and urinesamples were available.
These patients were stratified according to their serum
anti-JCV antibody IV (high (>1.5,n = 12); medium (1.5–0.9,
n = 2); low (<0.9, n = 1); negative (n = 6)). JCV-DNA could
not be detected in thewhole blood or stool samples. Four
urine samples had measurable JCV-DNA, ranging from
1.71×104–1.07×108international units (IU)/mL detected by
RT-PCR, corresponding to 4.62×104–9.85×106 copies/mL
measured byddPCR. All JCV variants were wild-type and
derived from patients with high antibody IV.Conclusion:
Stool-specific DNA extraction methods provided the highest
quality of DNA, while the sensitivity ofddPCR and RT- PCR
was comparable. Our findings do not support assessing stool
samples for PML risk stratificationin persons with MS.
Further studies are needed to explore where PML-associated
viral variants arise.},
cin = {INM-3},
ddc = {610},
cid = {I:(DE-Juel1)INM-3-20090406},
pnm = {5251 - Multilevel Brain Organization and Variability
(POF4-525) / DFG project 501362249 - Progressive multifokale
Leukenzephalopathie: Biomarker für eine frühzeitige
Diagnose, für die Risikovorhersage unter Immuntherapien
sowie für ein Ansprechen auf eine zielgerichtete Therapie
(501362249)},
pid = {G:(DE-HGF)POF4-5251 / G:(GEPRIS)501362249},
typ = {PUB:(DE-HGF)16},
pubmed = {38735204},
UT = {WOS:001243115500001},
doi = {10.1016/j.msard.2024.105664},
url = {https://juser.fz-juelich.de/record/1027025},
}